Maternal cadmium, placental PCDHAC1, and fetal development

Reproductive Toxicology

Volumn 65, Issue , 2016, Pages 263-271

  Everson, Todd M ^a   Armstrong, David A ^a   Jackson, Brian P ^b   Green, Benjamin B ^a   Karagas, Margaret R ^a   Marsit, Carmen J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH COLLEGE   (United States)

Author keywords

Expression; Fetal growth; Maternal cadmium; Methylation; PCDH; PCDHAC1; Placenta; Small for gestational age

Indexed keywords

CADMIUM; CADHERIN; DNA;

3' UNTRANSLATED REGION; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA METHYLATION; FEMALE; FETUS DEVELOPMENT; FETUS GROWTH; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; HEAD CIRCUMFERENCE; HUMAN; INFANT; INFANT LENGTH; LARGE FOR GESTATIONAL AGE; MALE; MATERNAL AGE; MATERNAL EXPOSURE; MOLECULAR DYNAMICS; NAIL; PCDHAC1 GENE; PROMOTER REGION; SMALL FOR DATE INFANT; STRUCTURAL EQUATION MODELING; TOENAIL; TOXICITY TESTING; TRANSCRIPTION INITIATION SITE; ANALYSIS; CHEMISTRY; FETOMATERNAL TRANSFUSION; GENETICS; METABOLISM; NEWBORN; PLACENTA; POLLUTANT; PREGNANCY;

CADHERINS; CADMIUM; DNA; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; NAILS; PLACENTA; PREGNANCY;

EID: 84984605186     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2016.08.011     Document Type: Article

References (51)

1. [1] Järup, L., Åkesson, A., Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 238 (2009), 201–208, 10.1016/j.taap.2009.04.020.
2. [2] Thompson, J., Bannigan, J., Cadmium: toxic effects on the reproductive system and the embryo. Reprod. Toxicol. 25 (2008), 304–315, 10.1016/j.reprotox.2008.02.001.
3. [3] EFSA (European Food Safety Authority), Cadmium dietary exposure in the European population. EFSA J., 10, 2012, 10.2903/j.efsa.2012.2551.
4. [4] Johri, N., Jacquillet, G., Unwin, R., Heavy metal poisoning: the effects of cadmium on the kidney. Biometals 23 (2010), 783–792, 10.1007/s10534-010-9328-y.
5. [5] Inaba, T., Kobayashi, E., Suwazono, Y., Uetani, M., Oishi, M., Nakagawa, H., et al. Estimation of cumulative cadmium intake causing Itai-itai disease. Toxicol. Lett. 159 (2005), 192–201, 10.1016/j.toxlet.2005.05.011.
6. [6] IARC (International Agency for Research on Cancer), Cadmium and Cadmium Compounds, IARC Monogr. Eval. Carcinog. Risks to Humans, 100C, 2012, 121–145 http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C-8.pdf.
7. [7] Wang, Z., Wang, H., Xu, Z.M., Ji, Y., Chen, Y.-H., Zhang, Z.-H., et al. Cadmium-induced teratogenicity: association with ROS-mediated endoplasmic reticulum stress in placenta. Toxicol. Appl. Pharmacol. 259 (2012), 236–247, 10.1016/j.taap.2012.01.001.
8. [8] Ronco, A.M., Urrutia, M., Montenegro, M., Llanos, M.N., Cadmium exposure during pregnancy reduces birth weight and increases maternal and foetal glucocorticoids. Toxicol. Lett. 188 (2009), 186–191, 10.1016/j.toxlet.2009.04.008.
9. [9] Lee, C.K., Lee, J.T., Yu, S.J., Kang, S.G., Moon, C.S., Choi, Y.H., et al. Effects of cadmium on the expression of placental lactogens and Pit-1 genes in the rat placental trophoblast cells. Mol. Cell. Endocrinol. 298 (2009), 11–18, 10.1016/j.mce.2008.09.028.
10. [10] Zhang, X., Xu, Z., Lin, F., Wang, F., Ye, D., Huang, Y., Increased oxidative DNA damage in placenta contributes to cadmium-induced preeclamptic conditions in rat. Biol. Trace Elem. Res. 170 (2016), 119–127, 10.1007/s12011-015-0438-9.
11. [11] Nakamura, Y., Ohba, K., Ohta, H., Participation of metal transporters in cadmium transport from mother rat to fetus. J. Toxicol. Sci. 37 (2012), 1035–1044.
12. [12] Nakamura, Y., Ohba, K., Suzuki, K., Ohta, H., Health effects of low-level cadmium intake and the role of metallothionein on cadmium transport from mother rats to fetus. J. Toxicol. Sci. 37 (2012), 149–156.
13. [13] Johnston, J.E., Valentiner, E., Maxson, P., Miranda, M.L., Fry, R.C., Maternal cadmium levels during pregnancy associated with lower birth weight in infants in a north carolina cohort. PLoS One, 9, 2014, e109661, 10.1371/journal.pone.0109661.
14. [14] Kippler, M., Tofail, F., Gardner, R., Rahman, A., Hamadani, J.D., Bottai, M., et al. Maternal cadmium exposure during pregnancy and size at birth: a prospective cohort study. Environ. Health Perspect. 120 (2012), 284–289, 10.1289/ehp.1103711.
15. [15] Llanos, M.N., Ronco, A.M., Fetal growth restriction is related to placental levels of cadmium, lead and arsenic but not with antioxidant activities. Reprod. Toxicol. 27 (2009), 88–92, 10.1016/j.reprotox.2008.11.057.
16. [16] Menai, M., Heude, B., Slama, R., Forhan, A., Sahuquillo, J., Charles, M.-A., et al. Association between maternal blood cadmium during pregnancy and birth weight and the risk of fetal growth restriction: the EDEN mother-child cohort study. Reprod. Toxicol. 34 (2012), 622–627, 10.1016/j.reprotox.2012.09.002.
17. [17] Lin, C.-M., Doyle, P., Wang, D., Hwang, Y.-H., Chen, P.-C., Does prenatal cadmium exposure affect fetal and child growth?. Occup. Env. Med. 68 (2011), 641–646, 10.1136/oem.2010.059758.
18. [18] Kim, Y., Ha, E.-H., Park, H., Ha, M., Kim, Y., Hong, Y.-C., et al. Prenatal lead and cadmium co-exposure and infant neurodevelopment at 6 months of age: the Mothers and Children's Environmental Health (MOCEH) study. Neurotoxicology 35 (2013), 15–22, 10.1016/j.neuro.2012.11.006.
19. [19] Schoeters, G., Hond, E.D.E.N., Zuurbier, M., Hazel, P.V.A.N.D.E.N., Stilianakis, N., Koppe, J.G., Cadmium and children: exposure and health effects. Acta Paediatr. 95 (2006), 50–54, 10.1080/08035320600886232.
20. [20] Yamada, H., Koizumi, S., DNA microarray analysis of human gene expression induced by a non-lethal dose of cadmium. Ind. Health. 40 (2002), 159–166.
21. [21] Yamada, H., Uenishi, R., Suzuki, K., Koizumi, S., Cadmium-induced alterations of gene expression in human cells. Environ. Toxicol. Pharmacol. 28 (2009), 61–69, 10.1016/j.etap.2009.02.007.
22. [22] Vidal, A.C., Semenova, V., Darrah, T., Vengosh, A., Huang, Z., King, K., et al. Maternal cadmium, iron and zinc levels DNA methylation and birth weight. BMC Pharmacol. Toxicol. 16 (2015), 1–9, 10.1186/s40360-015-0020-2.
23. [23] Kippler, M., Engström, K., Mlakar, S.J., Bottai, M., Ahmed, S., Hossain, M.B., et al. Sex-specific effects of early life cadmium exposure on DNA methylation and implications for birth weight. Epigenetics 8 (2013), 494–503, 10.4161/epi.24401.
24. [24] Hossain, M.B., Vahter, M., Concha, G., Broberg, K., Low-level environmental cadmium exposure is associated with DNA hypomethylation in argentinean women. Environ. Health Perspect. 120 (2012), 879–884, 10.1289/ehp.1104600.
25. [25] Vilahur, N., Vahter, M., Broberg, K., The epigenetic effects of prenatal cadmium exposure. Curr. Environ. Health Rep. 2 (2015), 195–203, 10.1007/s40572-015-0049-9.
26. [26] Kokkinos, M.I., Murthi, P., Wafai, R., Thompson, E.W., Newgreen, D.F., Cadherins in the human placenta − epithelial-mesenchymal transition (EMT) and placental development. Placenta 31 (2010), 747–755, 10.1016/j.placenta.2010.06.017.
27. [27] Cao, X., Lin, H., Muskhelishvili, L., Latendresse, J., Richter, P., Heflich, R.H., Tight junction disruption by cadmium in an in vitro human airway tissue model. Respir. Res., 16, 2015, 10.1186/s12931-015-0191-9.
28. [28] Pearson, C.A., Lamar, P.C., Prozialeck, W.C., Effects of cadmium on E-cadherin and VE-cadherin in mouse lung. Life Sci. 72 (2003), 1303–1320.
29. [29] Prozialeck, W.C., Lamar, P.C., Lynch, S.M., Cadmium alters the localization of N-cadherin, E-cadherin, and beta-catenin in the proximal tubule epithelium. Toxicol. Appl. Pharmacol. 189 (2003), 180–195, 10.1016/S0041-008X(03)00130-3.
30. [30] Chen, W.V., Maniatis, T., Clustered protocadherins. Development 3302 (2013), 3297–3302, 10.1242/dev.090621.
31. [31] Kawaguchi, M., Toyama, T., Kaneko, R., Hirayama, T., Kawamura, Y., Yagi, T., Relationship between DNA methylation states and transcription of individual isoforms encoded by the protocadherin-alpha gene cluster. J. Biol. Chem. 283 (2008), 12064–12075, 10.1074/jbc.M709648200.
32. [32] Severson, P.L., Tokar, E., Vrba, L., Waalkes, M., Futscher, B., Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation. Epigenetics 7 (2012), 1238–1248, 10.4161/epi.22163.
33. [33] Tasic, B., Nabholz, C.E., Baldwin, K.K., Kim, Y., Rueckert, E.H., Ribich, S.A., et al. Promoter choice determines splice site selection in Protocadherin alpha and gamma Pre-mRNA Splicing. Cell Press 10 (2002), 21–33.
34. [34] Katori, S., Hamada, S., Noguchi, Y., Fukuda, E., Yamamoto, T., Yamamoto, H., et al. Protocadherin-alpha family is required for serotonergic projections to appropriately innervate target brain areas. J. Neurosci. 22 (2009), 9137–9147, 10.1523/JNEUROSCI.5478-08.2009.
35. [35] Fenton, T.R., Kim, J.H., A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr., 13, 2013, 10.1186/1471-2431-13-59.
36. [36] Meller, M., Vadachkoria, S., Luthy, D.A., Williams, M.A., Evaluation of housekeeping genes in placental comparative expression studies. Placenta 26 (2005), 601–607, 10.1016/j.placenta.2004.09.009.
37. [37] Maccani, J.Z.J., Koestler, D.C., Lester, B., Houseman, E.A., Armstrong, D.A., Kelsey, K.T., et al. Placental DNA methylation related to both infant toenail mercury and adverse neurobehavioral outcomes. Environ. Health Perspect. 123 (2015), 723–729, 10.1289/ehp.1408561.
38. [38] Chen, Y., Lemire, M., Choufani, S., Butcher, D.T., Grafodatskaya, D., Zanke, B.W., et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8 (2013), 203–209, 10.4161/epi.23470.
39. [39] Johnson, W.E., Li, C., Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8 (2007), 118–127, 10.1093/biostatistics/kxj037.
40. [40] Rousseeuw, P., Croux, C., Todorov, V., Ruckstuhl, A., Salibian-barrera, M., Verbeke, T., et al. Robustbase: Basic Robust Statistics. R Package Version 0. 2015, 92–95 http://cran.r-project.org/package=robustbase.
41. [41] Rosseel, Y., Lavaan: an r package for structural equation. J. Stat. Softw., 48, 2012.
42. [42] Punshon, T., Li, Z., Marsit, C.J., Jackson, B.P., Baker, E.R., Karagas, M.R., Placental metal concentrations in relation to maternal and infant toenails in a U.S. cohort. Environ. Sci. Technol. 50 (2016), 1587–1594, 10.1021/acs.est.5b05316.
43. [43] Hayashi, S., Takeichi, M., Emerging roles of protocadherins: from self-avoidance to enhancement of motility. J. Cell Sci. 128 (2015), 1–10, 10.1242/jcs.166306.
44. [44] Anitha, A., Thanseem, I., Nakamura, K., Yamada, K., Iwayama, Y., Toyota, T., et al. Protocadherin alpha (PCDHA) as a novel susceptibility gene for autism. J. Psychiatry Neurosci. 38 (2013), 192–198, 10.1503/jpn.120058.
45. [45] Brown, N., Burgess, T., Forbes, R., McGillivray, G., Kornberg, A., Mandelstam, S., et al. 5q31.3 microdeletion syndrome: clinical and molecular characterization of two further cases. Am. J. Med. Genet. A 161A (2013), 2604–2608, 10.1002/ajmg.a.36108.
46. [46] Mikheev, A.M., Nabekura, T., Kaddoumi, A., Bammler, T.K., Govindarajan, R., Hebert, M.F., et al. Profiling gene expression in human placentae of different gestational ages: an OPRU* network and UW SCOR study. Reprod. Sci. 15 (2008), 866–877, 10.1177/1933719108322425.
47. [47] Huuskonen, P., Storvik, M., Reinisalo, M., Honkakoski, P., Rysa, J., Hakkola, J., et al. Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers. Clin. Pharmacol. Ther. 83 (2008), 542–550, 10.1038/sj.clp.
48. [48] He, K., Trace elements in nails as biomarkers in clinical. Eur. J. Clin. Invest. 41 (2011), 98–102, 10.1111/j.1365-2362.2010.02373.x.
49. [49] Kippler, M., Hoque, A.M.W., Raqib, R., Öhrvik, H., Ekström, E., Vahter, M., Accumulation of cadmium in human placenta interacts with the transport of micronutrients to the fetus. Toxicol. Lett. 192 (2010), 162–168, 10.1016/j.toxlet.2009.10.018.
50. [50] Yang, K., Julan, L., Rubio, F., Sharma, A., Guan, H., Cadmium reduces 11 beta-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells. Am. J. Physiol. Endocrinol. Metab. 290 (2006), E135–E142, 10.1152/ajpendo.00356.2005.
51. [51] Murphy, V.E., Smith, R., Giles, W.B., Clifton, V.L., Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr. Re 27 (2006), 141–169, 10.1210/er.2005-0011.